Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC228

Lyfjasamsetningarafurð sem inniheldur lyfjafræðilega viðunandi salt af úmeklidíníum (t.d. úmeklidíníumbrómíð) vílanteról eða lyfjafræðilega viðunandi salt þar af (t.d. vílanteróltrífenatat) og flútikasónfúróat

  • Status:
    Veitt
  • Application date:
    29.5.2018
  • Application published:
    15.6.2018
  • Grant published:
    15.11.2019
  • Max expiry date:
    16.11.2032
  • Medicine name:
    Trelegy Ellipta
  • Medicine for children:
    No

Timeline

Today
29.5.2018Application
15.6.2018Publication
15.11.2019Registration
16.11.2032Expires

Marketing license

  • IS authorization number:
    EU/1/17/1236/001-003
  • Date:
    30.11.2017
  • Foreign authorization number:
    EU/1/17/1236
  • Date:
    15.11.2017

Owner

  • Name:
    Glaxo Group Limited
  • Address:
    GSK Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY GB

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Upload documents